![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Alamolhoda SH, Yazdkhasti M, Namdari M, Zakariayi SJ, Mirabi P. 2020. Association between C-reactive protein and gestational diabetes: a prospective study. Journal of Obstetrics and Gynaecology 40:349–353.
- Alyas S, Roohi N, Ashraf S, Ilyas S, Ilyas A. 2019. Early pregnancy biochemical markers of placentation for screening of gestational diabetes mellitus (GDM). Diabetes and Metabolic Syndrome: Clinical Research and Reviews 13:2353–2356.
- Amirian A, Rahnemaei FA, Abdi F. 2020. Role of C-reactive Protein (CRP) or high-sensitivity CRP in predicting gestational diabetes Mellitus: systematic review. Diabetes & Metabolic Syndrome 14:229–236.
- Kansu-Celik H, Ozgu-Erdinc AS, Kisa B, Findik RB, Yilmaz C, Tasci Y. 2019. Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels. Archives of Endocrinology and Metabolism 63:121–127.
- Mostafa MK, Ouf TF, Abd Al-Aziz AF, Hegazy HA. 2019. The relation between serum C-Reactive protein level and gestational diabetes. The Egyptian Journal of Hospital Medicine 75:2149–2153.